|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Accounts receivable, net of allowances of $3,732 and $4,172, respectively | ||||||||||||||||||
| Contract assets - current, net | ||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||
| Income tax receivable | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||
| Contract assets - non-current, net | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities, Preferred Stock and Stockholders' Deficit | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||
| Income taxes payable | ||||||||||||||||||
| Tax Receivable Agreement liability | ||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||
| Contingent consideration payable - current | ||||||||||||||||||
| Deferred acquisitions consideration payable - current | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term debt | ||||||||||||||||||
| Tax Receivable Agreement liability - non-current | ||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||
| Operating lease liabilities - non-current | ||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||
| Contingent consideration payable - non-current | ||||||||||||||||||
| Deferred acquisition consideration payable | ||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 100,000 shares authorized; 80 Series A and 60 Series B convertible redeemable issued and outstanding, respectively | ||||||||||||||||||
| Total preferred stock, $0.0001 par value, 100,000 shares authorized; 80 Series A and 60 Series B convertible redeemable issued and outstanding, respectively | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 100,000 shares authorized; 80 Series A and 60 Series B convertible redeemable issued and outstanding, respectively, at March 31, 2024 | ||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 100,000 shares authorized; none issued and outstanding at December 31, 2022 | ||||||||||||||||||
| Common stock | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Class C common stock | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Treasury stock, at cost, 7 and 7 shares, respectively | ||||||||||||||||||
| Cumulative deficit | ||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||
| Total deficit | ||||||||||||||||||
| Total liabilities, preferred stock and stockholders' deficit | ||||||||||||||||||
| Common stock par value (usd per share) | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Class C common stock | ||||||||||||||||||
| Total common stock par value (usd per share) | ||||||||||||||||||
| Common stock authorized (in shares) | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Class C common stock | ||||||||||||||||||
| Total common stock authorized (in shares) | ||||||||||||||||||
| Common stock issued (in shares) | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Class C common stock | ||||||||||||||||||
| Common stock outstanding (in shares) | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Class C common stock | ||||||||||||||||||
| Total common stock outstanding (in shares) | ||||||||||||||||||
Loading...